Please ensure Javascript is enabled for purposes of website accessibility

3 Humongous Health-Care Stocks This Week

By Keith Speights – Feb 22, 2014 at 8:25AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Find out which healthcare stocks deserved gold medals this week.

Champions weren't just basking in glory at the Sochi Winter Olympic games this week. The world of health care produced quite a few stocks deserving gold medals in their own way. 

Breaking news about a big acquisition propelled one of our humongous health-care stocks higher this week. Accelerated approval from the U.S. Food and Drug Administration for a promising drug did the trick for another stock. And one huge winner's gains didn't have an obvious catalyst. 

Which health-care stocks claimed the thrill of victory this week? Find out by watching the slideshow below.

Keith Speights owns shares of Actavis. The Motley Fool has no position in any of the stocks mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Stocks Mentioned

Allergan Stock Quote
Allergan
AGN
China Biologic Products Stock Quote
China Biologic Products
CBPO

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.